[1]
R. Foley, C. Owen, S. Tabchi, and G. Razavi, “Panel Discussion: Treatment options for relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) patients”, Can Hematol Today, vol. 1, no. S10, Oct. 2022.